![]() |
|
|
American Health Foundation, Valhalla, NY 10595
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: colon cancer oligofructose inulin Bifidobacterium longum
| INTRODUCTION |
|---|
|
|
|---|
Among the types of dietary fiber, inulin and oligofructose, which
occur in common food stuffs such as chicory, leeks, garlic, onion,
artichoke and asparagus at high levels, are ß (2
1)D
fructans. They are fermented by colonic microflora and behave as
soluble fibers (Gibson and Roberfroid 1995
). It is of
great interest that they selectively stimulate the growth of
bifidobacteria at the expense of bacteriodes, clostridia or coliforms,
which are maintained at low levels (Gibson and Roberfroid 1995
, Gibson et al. 1995
). Bacterial
fermentation of these prebiotics produces short-chain fatty acids
(SCFA)2in the colon, including a small amount of butyric acid (Campbell et al. 1997
, Gibson and Roberfroid 1995
), which
has been shown to increase apoptosis in the colon (Hague et al. 1993
). Of special interest are the beneficial effects of
certain lactic acidproducing enterobacterial food supplements,
probiotics, in the prevention of cancer (Hitchins and McDonough 1989
, Le et al. 1986
). The lactic cultures,
which are primarily used for fermentation of milk and other dairy
products, have also been shown to possess antimutagenic and
anticarcinogenic properties (Bodana and Rao 1990
,
Goldin and Gorbach 1980
, Lidbeck et al. 1992
). Furthermore, there are studies to demonstrate that
cultures of bifidobacteria increase the host's immune response
(Sekine et al. 1995
). These observations raise the
possibility that selective fermentable, nondigestible oligosaccharides
that enhance the growth of bifidobacteria in the gut and cultures of
lactic acidproducing bacteria could potentially inhibit colon
carcinogenesis. It was, therefore, of interest to evaluate the
inhibitory properties and modes of action of prebiotics such as
oligofructose and inulin, and probiotics, including bifidobacteria,
against colon carcinogenesis.
| Inhibitory activity of oligofructose and inulin against colon carcinogenesis |
|---|
|
|
|---|
Studies were conducted in our laboratory to determine the
potential inhibitory properties of oligofructose (Raftilose) and inulin
(Raftiline) on azoxymethane (AOM)-induced colon carcinogenesis in male
F344 rats using colonic aberrant crypt foci (ACF) as end points
(Reddy et al. 1997
). In this study, groups of 7-wk-old
male F344 rats were fed the AIN-76A (control) and the experimental
diets containing 10% oligofructose (Raftilose P95) or inulin
(Raftiline HP). All rats received a subcutaneous injection of the
colon-specific carcinogen, AOM, dissolved in normal saline at a
dose rate of 15 mg/kg body weight, once weekly for 2 wk. The animals
were necropsied 7 wk later, and the ACF were visualized under light
microscopy in the formalin-fixed, unsectioned methylene
blue-stained colons. ACF were distinguished by their increased
size, more prominent epithelial cells and pericryptal space. AOM
treatment induced on the average ~120 ACF per colon (Table 1
); ACF were observed predominantly in the distal colon. Efficacy
end points used in this study were inhibition of the total number of
ACF per colon as well as the reduction of the number of multicrypt
clusters (
2) of aberrant crypts per focus. As summarized in Table 1
,
administration of oligofructose or inulin in the diet significantly
suppressed the total number of ACF per colon compared with the control
diet; the degree of inhibition was more pronounced in rats fed inulin
(P < 0.0006) than in those fed oligofructose
(P < 0.02). Crypt multiplicity in terms of two or
three aberrant crypts per focus were also inhibited significantly in
rats fed inulin (P < 0.020.0001) and oligofructose
(P < 0.040.01). These findings indicate that dietary
oligofructose and inulin inhibit ACF formation, an early preneoplastic
marker of malignant potential in the process of colon carcinogenesis,
suggesting that these agents may suppress colon tumorigenesis.
|
| Inhibitory activity of culutres of B. longum against colon carcinogenesis |
|---|
|
|
|---|
Studies were also conducted to evaluate the inhibitory properties of
lyophilized cultures of B. longum against AOM-induced
colonic ACF development (Kulkarni and Reddy 1994
). The
results indicate that dietary administration of lyophilized cultures of
B. longum at 1.5 and 3.0% levels significantly inhibited
the total ACF formation and crypt multiplicity (two, three, or four or
more crypts per focus). The results of this study provide evidence for
potential colon tumor-inhibitory properties of B.
longum.
Effect on AOM-induced colon tumorigenesis.
Because the lyophilized cultures of B. longum inhibited the
preneoplastic lesions in the colon, studies were conducted to determine
the colon tumor inhibitory properties of B. longum
(Singh et al. 1997
). Male F344 rats were fed the
modified AIN-76A diet containing 0 or 2% lyophilized cultures of
B. longum and subcutaneously administered AOM dissolved in
normal saline at a dose rate of 15 mg/kg body weight, once weekly, for
2 wk. Vehicle controls received subcutaneously an equal volume of
normal saline. Animals were maintained on control or experimental diets
until termination of the study at 40 wk after last AOM treatment.
Table 2
summarizes the AOM-induced tumors in the colon in terms of
tumor incidence (percentage of animals with tumors) and colon tumor
multiplicity (number of tumors per animal). Dietary administration of
B. longum cultures significantly inhibited the incidence of
colon adenocarcinomas (P < 0.05) and colon tumor
multiplicity in terms of tumors per animal (P < 0.001)
and tumors per tumor-bearing animal (P < 0.01).
|
The formation of mutagens upon broiling fish and meat was first
discovered by Sugimura et al. (1977)
. IQ, a heteroxyclic
aromatic amine produced from food pyrolysis, was first isolated from
broiled fish. Subsequently, it was isolated from a variety of broiled
or cooked fish and meat (Kasai et al. 1980
). IQ has a
multitarget organospecificity with specific cancer induction in the
Zymbal gland, skin, colon, oral cavity and mammary gland of rodents
(Sugimura et al. 1991
). Although it is not clear whether
these heterocyclic amines may contribute to human cancer development,
it is certain that these compounds are present in cooked foods and pose
a credible risk to humans.
Because IQ induces colon tumors in male and female rats and mammary
tumors in female rats, and bacterial cultures that ferment milk possess
anticarcinogenic properties, the possibility exists that these
bacterial cultures may prevent IQ-induced carcinogenesis.
Accordingly the inhibitory effect of lyophilized cultures of B.
longum on IQ-induced carcinogenesis was investigated in male
and female F344 rats (Reddy and Rivenson 1993
).
Beginning at 5 wk of age, male and female rats were divided into
various experimental groups and fed one of the high fat, semipurified
diets containing 0 and 0.5% lyophilized cultures of B.
longum with or without 125 ppm IQ. All rats were continued on this
regimen until the termination of the study at wk 58. The results
indicated that lyophilized cultures of B. longum
significantly inhibited the IQ-induced incidence (percentage of
animals with tumors) of colon tumors (100% inhibition) and
multiplicity of colon tumors (tumors per animal) in male rats (Table 2)
. In female rats, dietary supplement of B. longum cultures
also suppressed the IQ-induced mammary carcinogenesis to 50% of
that observed in animals fed the control diet. Mammary tumor
multiplicity (tumors per animal) was significantly (P
< 0.05) inhibited in female rats fed the diet containing B.
longum cultures. These findings suggest that dietary
bifidobacterium supplements inhibit IQ-induced colon tumors and to
a lesser extent mammary tumors in F344 rats.
| Possible mechanisms of colon cancer inhibition by prebiotics |
|---|
|
|
|---|
| Possible mechanism of colon cancer inhibition by B. longum |
|---|
|
|
|---|
Ras activation represents one of the earliest and most
frequently occurring genetic alterations associated with human cancers,
especially the cancer of the colon (Barbacid 1990
).
Elevated levels of ras-p21 have been correlated with
increased cell proliferation, histologic grade, nuclear anaplasia and
degree of undifferentiation (Kotsinas et al. 1993
). In
experiments in which mutated ras genes are selectively
inactivated, the preexisting tumor phenotype reverts to a more normal
form, indicating that activated ras may be necessary for the
maintenance of malignant behavior (Mukhopadhyay et al. 1991
). We also analyzed the modifying effects of
B. longum cultures on ras p-21 expression to
determine whether the inhibition of colon tumorigenesis is associated
with the modulation of ras p-21 activity. The results
summarized in Table 3
demonstrate that dietary B. longum cultures
significantly suppressed the expression of total and mutated
ras p-21 in the colonic mucosa and tumors compared with the
control diet. This inhibitory effect of B. longum cultures
on ras p-21 expression was again strongly correlated with
colon tumor outcome. As regards the mechanism of inhibition of
ras activation afforded by B. longum
cultures, it is likely that bifidobacterial cells, as a biological
response modifier, modulate the induction of the methylguanine repair
protein, O6-methylguanine DNA methyltransferase,
which acts as a suicide enzyme that stoichiometrically accepts a methyl
group onto itself, restoring the original guanine in DNA by in situ
demethylation (Pegg and Dolan 1989
). To our knowledge,
no other data exist pertaining to the modulation of ras
function by lactic cultures. It is clear from these results that
B. longumaugmented suppression of AOM-induced
ras activity may interfere with the progression of events
leading to colon tumor development.
|
| CONCLUSION |
|---|
|
|
|---|
| FOOTNOTES |
|---|
2 Abbreviations used: ACF, aberrant crypt foci;
AOM, azoxymethane; IQ, 2-amino-3-methylimidazo[4,5-f]quinoline; ODC,
ornithine decarboxylase; SCFA, short-chain fatty acids. ![]()
| REFERENCES |
|---|
|
|
|---|
1. Barbacid M. Ras oncogenes: their role in neoplasia. Eur. J. Clin. Investig. 1990;20:225-235[Medline]
2. Biasco G., Paganelli G. M., Brandi G. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital. J. Gastroenterol. 1991;23:142[Medline]
3. Bodana A. R., Rao D. R. Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. J. Dairy Sci. 1990;73:3379-3384[Abstract]
4.
Campbell J. M., Fahey G. C., Jr, Wolf B. W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and micorflora in rats. J. Nutr. 1997;127:130-136
5. Gamet L., DaVaind D., Denis-Poouxviel C., Ramsey C., Murat J. C. Effects of short-chain fatty acids on growth and differentiation of the human colon cancer cell line HT 29. Int. J. Cancer 1992;52:286-289[Medline]
6. George A.J.T. Surface-bound cytokines: a possible effector mechanism in bacterial immunity?. Immunol. Today 1994;15:88-89[Medline]
7. Gibson G. R., Beatty E. R., Wang X., Cummings J. H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-982[Medline]
8. Gibson G. R., Roberfroid M. B. Dietary modulation of the human colon microbiota: introducing the concept of prebiotics. J. Nutr. 1995;125:1401-1412
9. Goldin B. R., Gorbach S. L. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 1980;64:263-265
10. Hague A., Manning A. M., Hanlon K. A., Hutschtscha L. I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumor cell lines in p53-independent pathway: implications for possible role of dietary fiber in the prevention of large bowel cancer. Int. J. Cancer 1993;55:498-505[Medline]
11.
Hitchins A. D., McDonough F. E. Prophylactic and therapeutic aspects of fermented milk. Am. J. Clin. Nutr. 1989;49:675-684
12.
Howe G. R., Benito E., Castello R. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl. Cancer Inst. 1992;84:1887-1896
13. Kasai H., Nishimura S., Wakabayashi K., Nagao M., Sugimura T. Chemical synthesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a potent mutagen isolated from broiled fish. Proc. Jpn. Acad. 1980;56B:382-384
14. Kotsinas A., Spandidos D. A., Romanowski P., Wyllie A. H. Relative expression of wild-type and activated Ki-ras2 oncogene in colorectal carcinomas. Int. J. Oncol. 1993;3:841-845
15. Kohwi Y., Imai K., Tamura Z., Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice. Gann 1978;69:163-168
16. Kulkarni N., Reddy B. S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial ß-glucuronidase. Proc. Soc. Exp. Biol. Med. 1994;207:278-283[Abstract]
17. Le M. G., Moulton L. H., Hill C., Krammer A. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Natl. Cancer Inst. 1986;77:633-636
18. Lidbeck A., Nord C. E., Gutafsson J.-A., Rafter J. Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur. J. Cancer Prev. 1992;1:341-353[Medline]
19. Luk G. D., Baylin S. B. Ornithine decarboxylase as biological marker in familial colonic polyps. N. Engl. J. Med. 1984;311:80-83[Abstract]
20.
Luk G. D., Zhang S. Z., Hamilton S. R. Effects of timing of administration and dose of difluoromethylornithine on rat colonic carcinogenesis. J. Natl. Cancer Inst. 1989;81:421-427
21.
McLellan E. A., Medline A., Brid R. P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 1991;51:5270-5274
22.
Mukhopadhyay T., Tainsky M., Cavander A. C., Roth J. A. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 1991;51:1744-1748
23. Newmark H. L., Lupton J. R., Young C. W. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett 1994;78:1-5[Medline]
24. Okawa T., Niibe H., Arai T., Sekiba K., Noda K., Takeuchi S., Hashimoto S., Ogawa N. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. Cancer 1993;72:1949-1954[Medline]
25. Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer Statistics, 1997. CA-Cancer J. Clin. 1997;47:5-27[Medline]
26. Pegg A. E., Dolan M. E. Investigation of sequence specificity in DNA alkylation and repair using oligodeoxynucleotide substrate. Lambart M. W. Laval J. eds. DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells 1989:45-59 Plenum Press New York, NY.
27. Porter C. W., Herrera-Ornelas L., Clark J., Pera P., Petrelli N. J., Mittleman A. Polyamine biosynthetic activity in normal and neoplastic human colorectal tissue. Cancer (Phila.) 1987;60:1275-1281[Medline]
28. Pretlow T. P., O'Riordan M. A., Pretlow T. G., Stellato T. A. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J. Cell. Biochem. 1992;16G(suppl.):55-62
29. Reddy B. S. Dietary fiber and colon cancer: animal model studies. Prev. Med. 1995;6:559-565
30. Reddy B. S., Engle A., Simi B., Goldman M. Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology 1992;102:1475-1482[Medline]
31.
Reddy B. S., Hamid R., Rao C. V. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997;18:1371-1374
32.
Reddy B. S., Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 1993;53:3914-3918
33. Sekine K., Ohta J., Onishi M., Tatsuki T., Shimokawa Y., Toida T., Kawashima T., Hashimoto Y. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol. Pharm. Bull. 1995;18:148-153[Medline]
34. Singh J., Kelloff G., Reddy B. S. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Cancer Epidemiol. Biomark. Prev. 1992;1:405-411[Abstract]
35. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., Reddy B. S. Bifidobacterium longum, a lactic acid-producing intestinal microflora inhibit colon cancer and modulate the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997;18:1371-1377
36. Steinmetz K. A., Porter J. D. A review of vegetables, fruits, and cancer. 1. Epidemiology. Cancer Causes Control 1991;2:325-357[Medline]
37. Sugimura T., Nagao M., Kawachi T., Honda M., Yahagi T., Seino Y., Sato S., Matsukura N., Matsushima T., Shirai A., Sawamura M., Matsumoto H. Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods. Hiatt H. Watson J. D. Winsten J. A. eds. Origins of Human Cancer 1977:1561-1577 Cold Spring Harbor Laboratory Cold Spring Harbor, NY.
38. Sugimura T., Wakabayashi K., Ohgaki H., Takayama S., Nagao M. G., Esumi H. Heterocyclic amines produced in cooked food: unavailable zenobiotics. Ernster L. eds. Xenobiotics and Cancer 1991:279-288 Japan Scientific Society Press Tokyo, Japan.
39.
Vivona A. A, Shpitz B., Medline A., Bruce W. R, Hay K., Ward M. A., Stern H. S., Gallinger S. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis (Lond.) 1993;14:1777-1781
40. Wang X., Gibson G. R. Effect of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacteriol. 1993;75:373-380[Medline]
41.
Wargovich M. H., Chen D. D., Jimenez A., Steele V. E., Velasco M., Stephens C., Price R., Gray K., Kelloff G. J. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomark. Prev. 1996;5:355-360
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||